AlphaGraphs
Expedia Q4 2025 Revenue Up 11%, B2B Segment Surges
Expedia Group Q4 2025 Financial Overview Expedia Group Inc. reported mixed financial results for the fourth quarter of...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,198 articles
Analysis
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook
Shares of Bruker Corporation (Nasdaq: BRKR) were down sharply in early trade on Friday, retreating around 10% to...
Analysis
Expedia Group Beats Q4 Estimates on B2B Strength; Issues Optimistic 2026 Guidance
Expedia Group Inc. (NASDAQ: EXPE) reported fourth-quarter financial results that surpassed Wall Street expectations on both the top...
Analysis
Zoetis Delivers Strong Q4 2025 Beat; Sets Sights on Long-Acting Growth in 2026
Zoetis Inc. (NYSE: ZTS) concluded its fiscal year 2025 on a high note, reporting fourth-quarter financial results that...
Analysis
Kimco Realty Posts Record Occupancy and Robust FFO Growth in Q4 2025
Kimco Realty (NYSE: KIM) reported a standout fourth quarter for 2025, marked by record-high occupancy levels and a...
Analysis
IFF Shares Slip After Q4 Results; FY2025 Sales Decline, EBITDA at $2.09 Billion
Stock Performance & Trading Context International Flavors & Fragrances Inc. (NYSE: IFF) shares fell about 2% intraday...
Analysis
PHINIA Inc. Posts 13% Q4 EBITDA Margin, Expands Share Repurchase Program
PHINIA Inc. (NYSE: PHIN) reported its fourth-quarter and full-year 2025 financial results, concluding its second full year as...
Analysis
PBF Energy Inc. Reports Q4 Net Income of $79.1M Amid Refinery Restoration Efforts
PBF Energy Inc. (NYSE: PBF) reported a return to profitability in the fourth quarter of 2025, buoyed by...
Analysis
CBRE Shares Slide Despite Record Q4 Revenue; 2025 Core EPS, Cash Flow Climb
CBRE Group, Inc. (NYSE: CBRE) shares fell 12.5% intraday Thursday. This drop followed earnings amid broader commercial real...
Analysis
Karyopharm Therapeutics Inc Shares Rise After Q4 2025 Results
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Shares closed at $6.31 on the Nasdaq in the most recent session, reflecting...
Analysis
Diebold Nixdorf Reports Higher Q4 Revenue and Margin Expansion, Issues 2026 Guidance
Diebold Nixdorf Inc. (NYSE: DBD) reported a robust conclusion to fiscal year 2025, marked by record free cash...
Analysis
Perfect Moment Ltd Shares Rise as Company Reports Q3 2026 Results
Perfect Moment Ltd (NYSE: PMNT) closed today at $0.38, up 4.1% intraday, after releasing its fiscal third quarter...